Early Treatment of Anterior Open Bite Using the Rapid Molar Intruder
Launched by DAMASCUS UNIVERSITY · Dec 11, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
Many appliances have been used to treat skeletal anterior open bite (AOB) malocclusion, such as removable appliances, extra-oral appliances (vertical chin cup and vertical head gear), fixed appliances, Orthognathic surgery and functional appliances. Treatment with these appliances produces soft and hard dentofacial tissue changes. Many studies have been carried out in order to study these changes.
In this study, the investigators treated AOB using RMI. Patients were divided into two groups to evaluate the efficacy of RMI.
RMI group: Rapid molar intruder was applied. Control group: Untreat...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients in the mixed dentition
- • 2. Chronological age between 8 and 12 years
- • 3. skeletal class I or II malocclusion
- • 4. Skeletal anterior open bite was assessed clinically and then confirmed radiographically: SN/GoMe was greater than 33°, MM was greater than 27
- • 5. No general problems
- • 6. Good oral health
- Exclusion Criteria:
- • 1. Presence of periodontal diseases
- • 2. Presence of general diseases, syndromes or cleft lip and palate
- • 3. Patients with previous orthodontic treatment
Trial Officials
Hammam Zeidan, DDS,MSc
Principal Investigator
Department of Orthodontics, University of Al-Baath Dental School, Hama, Syria.
Amjad A Hasan, DDS,MSc
Principal Investigator
Department of orthodontics, Damascus University, Syria
Mohammad Y. Hajeer, DDS,MSc,PhD
Study Director
Department of orthodontics, Damascus University, Syria
Azzam Al-Jundi, DDS,MSc,PhD
Study Director
Department of Orthodontics, University of Hama, Dental School, Hama, Syria.
About Damascus University
Damascus University, a prestigious institution located in Syria, is committed to advancing medical research and healthcare innovation through its clinical trial initiatives. With a focus on fostering collaboration between academia and clinical practice, the university aims to enhance the understanding of various medical conditions and improve patient outcomes. By leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, Damascus University strives to contribute to the global body of knowledge in the medical field and support the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Damascus, , Syrian Arab Republic
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials